agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
0.7242
-0.0861 (-10.63%)
At close: Nov 4, 2025, 4:00 PM EST
0.7025
-0.0217 (-3.00%)
Pre-market: Nov 5, 2025, 5:20 AM EST
agilon health Revenue
agilon health had revenue of $1.44B in the quarter ending September 30, 2025, a decrease of -1.08%. This brings the company's revenue in the last twelve months to $5.89B, up 5.21% year-over-year. In the year 2024, agilon health had annual revenue of $6.06B with 40.41% growth.
Revenue (ttm)
$5.89B
Revenue Growth
+5.21%
P/S Ratio
0.05
Revenue / Employee
$5,469,862
Employees
1,076
Market Cap
300.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.06B | 1.74B | 40.41% |
| Dec 31, 2023 | 4.32B | 1.93B | 80.74% |
| Dec 31, 2022 | 2.39B | 866.73M | 56.97% |
| Dec 31, 2021 | 1.52B | 303.16M | 24.88% |
| Dec 31, 2020 | 1.22B | 423.92M | 53.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
AGL News
- 8 hours ago - agilon health, inc. (AGL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 14 hours ago - agilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook - Business Wire
- 8 days ago - Halper Sadeh LLC Encourages agilon health, inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 4 weeks ago - agilon health Sets Date to Report Third Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - AGILON HEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL - Business Wire
- 6 weeks ago - AGILON HEALTH INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. – AGL - GlobeNewsWire
- 7 weeks ago - agilon health to Participate in the 2025 Jefferies Healthcare Services Conference - Business Wire
- 7 weeks ago - AGILON HEALTH INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL - PRNewsWire